37 CFR 1.102 - Advancement of examination

Cite as37 CFR 1.102
    • This document is available in original version only for vLex customers

      View this document and try vLex for 7 days
    • TRY VLEX
131 practice notes
  • Patent cases: Patent business goals; implementation,
    • United States
    • Federal Register October 05, 1998
    • October 5, 1998
    ...Procedure (6th ed., rev. 3, July 1997) (MPEP). While the rules of practice do provide for the advancement of applications for examination (37 CFR 1.102) and suspension of action in an application (37 CFR 1.103), the current procedures are not sufficiently tailored to the varied needs of the......
  • Legal Framework for Electronic Filing System - Web (EFS-Web)
    • United States
    • Federal Register October 27, 2009
    • October 27, 2009
    ...for inter partes reexamination under 35 U.S.C. 311 for utility or design patents; 8. Petitions to make special based on age under 37 CFR 1.102(c); and 9. Petitions to accept an unintentionally delayed payment of maintenance fee under 37 CFR 1.378(c), and payments of maintenance fees when su......
  • Select Creations, Inc. v. Paliafito America, Inc., No. 91-C-1240.
    • United States
    • United States District Courts. 7th Circuit. United States District Court of Eastern District of Wisconsin
    • December 21, 1992
    ...the multi-layer structure as recited in lines 5-14 of claim 1." (DX 104, at PTO 65.) 124. In the "Petition to Make Special under 37 C.F.R. § 1.102(d)," transmitted to the PTO by means of interstate facsimile, Nowak warranted to the PTO that he "had made or caused to be made a careful and th......
  • Khoja v. Orexigen Therapeutics, Inc., Case No.: 15-CV-540 JLS (JLB)
    • United States
    • United States District Courts. 9th Circuit. United States District Court (Southern District of California)
    • May 19, 2016
    ...ECF No. 62–10 (emphasis in original).) Defendant Orexigen also requested prioritized examination of the '810 Application pursuant to 37 C.F.R. § 1.102(e). (Id. at 9–10.)On September 10, 2014, the FDA approved Contrave for commercial use (CC ¶¶ 14, 55, 126, ECF No. 55), and on November 26, 2......
  • Request a trial to view additional results
48 cases
  • Select Creations, Inc. v. Paliafito America, Inc., No. 91-C-1240.
    • United States
    • United States District Courts. 7th Circuit. United States District Court of Eastern District of Wisconsin
    • December 21, 1992
    ...the multi-layer structure as recited in lines 5-14 of claim 1." (DX 104, at PTO 65.) 124. In the "Petition to Make Special under 37 C.F.R. § 1.102(d)," transmitted to the PTO by means of interstate facsimile, Nowak warranted to the PTO that he "had made or caused to be made a careful and th......
  • Khoja v. Orexigen Therapeutics, Inc., Case No.: 15-CV-540 JLS (JLB)
    • United States
    • United States District Courts. 9th Circuit. United States District Court (Southern District of California)
    • May 19, 2016
    ...ECF No. 62–10 (emphasis in original).) Defendant Orexigen also requested prioritized examination of the '810 Application pursuant to 37 C.F.R. § 1.102(e). (Id. at 9–10.)On September 10, 2014, the FDA approved Contrave for commercial use (CC ¶¶ 14, 55, 126, ECF No. 55), and on November 26, 2......
  • Dresser Industries, Inc. v. Ford Motor Co., Civ. A. No. CA3-80-1470-G.
    • United States
    • United States Courts of Appeals. United States Court of Appeals (10th Circuit)
    • October 15, 1981
    ...will be resolved with greater dispatch than reissue applications filed in the midst of patent litigation, however, is unclear. Under 37 C.F.R. § 1.102, reissue applications arising out of stayed litigation are to be given "priority" over initial applications and other reissue applications.3......
  • Gentile v. Franklin Sports, Inc., No. CIV. 01-10332-NG.
    • United States
    • United States District Courts. 1st Circuit. United States District Courts. 1st Circuit. District of Massachusetts
    • July 1, 2002
    ...allowable if rewritten in an independent form. (Id.). Shortly thereafter, in or about September 1995, Gentile filed a petition under 37 C.F.R. § 1.102(d) to have his application advanced out of turn due to the entry into the market of Sun Hockey's Zero Ball which he believed infringed on hi......
  • Request a trial to view additional results
47 firm's commentaries
  • MBHB Snippets: Review of Developments in Intellectual Property Law - Volume 8, Issue 3 - Summer 2010
    • United States
    • JD Supra United States
    • September 1, 2010
    ...the USPTO queue.38 Advantageously, this can be done without meeting the requirements for expediting prosecution of applications under 37 C.F.R. § 1.102,39 and without conducting a pre-examination search or providing an accelerated examination support document, as required by the Accelerated......
  • MBHB Snippets: Review of Developments in Intellectual Property Law - Winter 2013 - Volume 11, Issue 1
    • United States
    • JD Supra United States
    • February 19, 2013
    ...Control Procedures under Leahy-Smith America Invents Act, 76 Fed. Reg. 59050-55, (Sept. 23, 2011) [hereinafter Track 1]; see also 37 C.F.R. § 1.102(e) (2012). 2 USPTO, Data Visualization Center: Your Window to the USPTO, http://www.uspto. gov/dashboards/patents/main.dashxml (last visited Ja......
  • An Examination 'Off-Ramp' For Motions To Amend Still Raises Hopes And Questions
    • United States
    • Mondaq United States
    • January 10, 2017
    ...prosecution, the Office aims to provide a final disposition within 12 months for prioritized examination under 35 U.S.C. § 111(a) and 37 CFR § 1.102(e)(1) ("Track One") which are given special status. See M.P.E.P. § 708.02(b). Thus, the Office has practices and procedures in place for reexa......
  • An Examination “Off-Ramp” For Motions To Amend Still Raises Hopes and Questions
    • United States
    • JD Supra United States
    • January 6, 2017
    ...prosecution, the Office aims to provide a final disposition within 12 months for prioritized examination under 35 U.S.C. § 111(a) and 37 CFR § 1.102(e)(1) (“Track One”) which are given special status. See M.P.E.P. § 708.02(b). Thus, the Office has practices and procedures in place for reexa......
  • Request a trial to view additional results
3 books & journal articles
  • Patent Prosecution
    • United States
    • ABA General Library New practitioner’s guide to intellectual property Patents
    • May 16, 2012
    ...Additional reasons for grant of a petition to make special include applications concerning recombinant DNA research, cancer and HIV/ 25. 37 C.F.R. §1.102. Patent AIDS cures and treatments, superconductivity technologies, and technologies for countering terrorism. Finally, even if the techno......
  • 3D Printing and Why Lawyers Should Care, 0219 KSBJ, 88 J. Kan. Bar Assn 2, 28 (2019)
    • United States
    • Kansas Bar Journal Nbr. 2019, January 2019
    • January 1, 2019
    ...January 10, 2018. [74] Id. [75] Id. [76] Id.. [77] 35 U.S.C. § 271(b). [78] See 37 CFR § 1.102(e) and the Manual of Patent Examining Procedures at § [79] See 18 U.S.C. § 1836(b)(1). [80] See K.S.A. §§ 60-3320 through 60-3330 (2011). [81] Technical Considerations for Addi......
  • Managing Patent Prosecution
    • United States
    • ABA General Library The technology transfer law handbook
    • January 1, 2014
    ...to ile such a petition (including inventions enhancing environmental quality, developing or conserving energy resources, 79. See 37 C.F.R. § 1.102; MPEP, supra note 41, § JOHN RITTER AND SEAN D. SOLBERG FIGURE 2‑7 MANAGING PATENT PROSECUTION or countering terrorism), but now those applicati......
4 forms
  • Certification and Request for COVID-19 Prioritized Examination Pilot Program under 37 CFR 1.102(e)-SB/450
    • United States
    • United States Patent and Trademark Office, Patent Trial and Appeal Board
    • Invalid date
    ...Prioritized Examination Request PTO/SB/450 (05-20) CERTIFICATION AND REQUEST FOR COVID-19 PRIORITIZED EXAMINATION PILOT PROGRAM UNDER 37 CFR 1.102(e) (Page 1 of First Named Inventor: I Title of Invention: Nonprovisional Application Number (if known): I APPLICANT HEREBY CERTIFIES THE FOLLOWI......
  • Certification and Request for Prioritized Examination Under 37 CFR 1.102(e)-AIA/424
    • United States
    • United States Patent and Trademark Office, Patent Trial and Appeal Board
    • Invalid date
    ...TRACK1.REQ Document Description: TrackOne Request PTO/AIA/424 (04-14) CERTIFICATION AND REQUEST FOR PRIORITIZED EXAMINATION UNDER 37 CFR 1.102(e) (Page 1 of First Named Inventor: Nonprovisional Application Number (if known): Title of Invention: APPLICANT HEREBY CERTIFIES THE FOLLOWING AND R......
  • Certification and Petition to Make Special under the Climate Change Mitigation Pilot Program-SB/457
    • United States
    • United States Patent and Trademark Office, Patent Trial and Appeal Board
    • Invalid date
    ...understands that any required application size fee must be paid for the application. The fee for a petition to make special under 37 CFR 1.102(d) has been waived for this pilot 10. The applicant agrees to the following: (a) the application may not contain, or be amended to contain, more tha......
  • Certification and Petition to Make Special under the Cancer Moonshot Expedited Examination Pilot Program-SB/465
    • United States
    • United States Patent and Trademark Office, Patent Trial and Appeal Board
    • Invalid date
    ...EXPEDITED EXAMINATION PILOT PROGRAM (“PROGRAM”) FOR THE ABOVEIDENTIFIED APPLICATION. (The fee for a petition to make special under 37 CFR 1.102(d) has been waived for this program. For information regarding the requirements, conditions, and guidelines of the program, see the 2022 Federal Re......

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT